Picture EBD Group ChinaBio Partnering Forum 2022 650x100
Organisation › Details

CovalX AG

CovalX is the market leader in intact protein complex analysis using high mass MALDI based technology with headquarters in Zürich, Switzerland and a North American subsidiary in Saugus, MA. CovalX also supports sales/distribution across Europe, in Japan, Korea and Russia. The technology and applications are protected by a strong patent portfolio. Target groups consist primarily of life science research laboratories and pharmaceutical and biotechnology companies worldwide. CovalX focuses on biotech analytics as the prime area for future growth. The company currently has released its third generation of high mass MALDI detection systems on the market with a range of stabilization chemistries and data analysis software for applications characterizing protein interactions. CovalX also offers a full CRO analytics service featuring all of its novel applications directly to customer. Based in Zürich, Switzerland, the company is privately held. *


Period Start 2007-06-02 renamed
  Group CovalX (Group)
  Predecessor CovalX GmbH
Products Industry MALDI-TOF mass spectrometry technology
  Industry 2 mass spectrometry services (MS services)
Region Region Schlieren ZH
  Country Switzerland
  Street 11a Grabenstr.
  City 8952 Schlieren ZH
  Tel +41-44-755-7000
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: 
Record changed: 2019-06-09


Picture [iito] [LSE] Business Portal 650x200px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Berlin Partner Health Capital Computational Biology 2022 650x300px

» top